Sharon J. Diskin
Impact in
- Neurology top 0.5%
- Neuroblastoma Research and Treatments
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Neurology 47
- Neuroblastoma Research and Treatments 47
-
- Cancer, Hypoxia, and Metabolism 19
- Cancer Genomics and Diagnostics 5
- Co-authors
- John M. MarisKristina A. ColeEdward F. AttiyehMario CapassoHåkon HåkonarsonYaël P. MosséMarcella DevotoMaura Diamond
- Journals
- Cancer Research (11 papers)JNCI Journal of the National Cancer Institute (7 papers)Genome Research (4 papers)Bioinformatics (3 papers)PLoS Genetics (3 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Sharon J. Diskin
63 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 101
- Neurology 1.4k
- Cancer Research 1.3k
- Aging 54
- Genetics 787
- Molecular Biology 1.9k
Countries citing papers authored by Sharon J. Diskin
This map shows the geographic impact of Sharon J. Diskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon J. Diskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon J. Diskin more than expected).
Fields of papers citing papers by Sharon J. Diskin
This network shows the impact of papers produced by Sharon J. Diskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon J. Diskin. The network helps show where Sharon J. Diskin may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharon J. Diskin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 10 | |
| 4 | 2020 | 14 | |
| 5 | 2020 | 56 | |
| 6 | 2020 | 36 | |
| 7 | 2017 | 63 | |
| 8 | 2015 | 120 | |
| 9 | 2015 | 207 | |
| 10 | 2015 | 93 | |
| 11 | 2014 | 79 | |
| 12 | 2014 | 6 | |
| 13 | 2013 | 308 | |
| 14 | 2012 | 16 | |
| 15 | 2012 | 28 | |
| 16 | 2009 | 66 | |
| 17 | 2008 | 242 | |
| 18 | The microRNA miR-34a is a candidate 1p36 tumor suppressor gene in neuroblastoma | 2007 | 1 |
| 19 | 2007 | 31 | |
| 20 | 2003 | 88 |
About Sharon J. Diskin
Sharon J. Diskin is a scholar working on Neurology, Cancer Research, Oncology, Genetics and Molecular Biology, having authored 65 papers that have together received 3.3k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (47 papers), Cancer, Hypoxia, and Metabolism (19 papers), Lung Cancer Research Studies (13 papers), Genomic variations and chromosomal abnormalities (8 papers), Cancer therapeutics and mechanisms (6 papers), Genetics and Neurodevelopmental Disorders (5 papers), Cancer Genomics and Diagnostics (5 papers) and Mitochondrial Function and Pathology (4 papers). The work is most often cited by research in Neurology (1.4k citations), Cancer Research (1.3k citations), Aging (54 citations), Genetics (787 citations) and Molecular Biology (1.9k citations). Sharon J. Diskin has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include John M. Maris, Kristina A. Cole, Edward F. Attiyeh, Mario Capasso, Håkon Håkonarson, Yaël P. Mossé, Marcella Devoto, Maura Diamond, Derek A. Oldridge and Achille Iolascon. Their work appears in journals such as Cancer Research, JNCI Journal of the National Cancer Institute, Genome Research, Bioinformatics and PLoS Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.